Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,815.60
(
-0.53%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
91.83
(
-0.90%
)
Bitcoin
75,228.50
(
1.85%
)
News Focus
News Focus
Post# of 257426
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: asmarterwookie post# 189050

Monday, 10/03/2016 1:07:42 PM

Monday, October 03, 2016 1:07:42 PM

Post# of 257426
Wook...many months have passed now and it looks like the FDA may have seen the 100%+ MOS improvement on the phase III Sunrise. ESMO has the first crack possibly....at releasing the Embargoed biomarker data on Oct 10

One week away....NO reverse split and an easy climb back to $5+ coming....just as was seen back in Sept 2012

Unbelievable that many did not realize it was sabotage all along

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today